Drugs / valsartan/sacubitril
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02787798 | Oct 2016 → Jan 2018 | heart failure | University Hospital, Toulouse | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | valsartan/sacubitril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02787798 ↗ |
| Action | Inhibit | “double inhibition of AT1 receptor and neprilysin activity” NCT02787798 ↗ |